Keizo Yoshida

Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients

Keizo Yoshida, Kenichi Ito, Kazuhiro Sato et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2002 · 229 citations

Medicine, Pharmacology, Psychiatry +16

Prediction of Antidepressant Response to Milnacipran by Norepinephrine Transporter Gene Polymorphisms

Keizo Yoshida, Hitoshi Takahashi, Hisashi Higuchi et al. · American Journal of Psychiatry · 2004 · 158 citations

Medicine, Pharmacology, Psychiatry +17

Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409

Yasuhiro Kita, Yoshimi Hirasawa, Kazuhiro Maeda et al. · European Journal of Pharmacology · 1994 · 112 citations

Medicine, Neuroscience, Pharmacology +7

Discovery of 6-Oxo-3-(2-phenylpyrazolo[1,5-<i>a</i>]pyridin-3-yl)-1(6<i>H</i>)-pyridazinebutanoic Acid (FK 838):  A Novel Non-Xanthine Adenosine A₁Receptor Antagonist with Potent Diuretic Activity

Atsushi Akahane, Hirohito Katayama, Takafumi Mitsunaga et al. · Journal of Medicinal Chemistry · 1999 · 102 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +6

Monoamine oxidase: A gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder

Keizo Yoshida, Shingo Naito, Hitoshi Takahashi et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2002 · 91 citations

Medicine, Pharmacology, Psychiatry +17